Oncology Medical News about Thalassemia

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Advances in the Prevention and Treatment are Changing Thalassemia from a Fatal to a Chronic Disease. Experience from a Cyprus Model and its Use as a Paradigm for Future Applications
Hemoglobin, 10/23/09

Kolnagou A et al. – The introduction of effective chelation therapy protocols using primarily deferiprone (L1) in combination with deferoxamine (DFO) resulted in the reduction of iron overload induced cardiac failures, which is the main cause of death in thalassemia major. Despite their chronic condition and tedious clinical management many patients are successful professionals, married and have children. The advancement in treatment is transforming thalassemia from a fatal to a chronic condition and some families are opting for giving birth to a thalassemic child rather than abortion.

<< Previous
E-cadherin polymorphisms and breast cancer susceptibility: a...

Next >>
Expression of Nucleostemin, epidermal growth factor and epidermal...

Interaction of malaria with a common form of severe thalassemia in an Asian population
Proceedings of the National Academy of Sciences of the United States of America, 11/04/09 Relevance Score: 90%

Beta-Thalassemia in the Korean population
International Journal of Hematology, 10/12/09 Relevance Score: 90%

Effect of combination therapy of hydroxyurea with l-carnitine and magnesium chloride on hematologic parameters and cardiac function of patients with beta-thalassemia intermedia
European Journal of Haematology, 11/04/09 Relevance Score: 89%

Thalassemia Incidence and Treatment in China with Special Reference to Shenzhen City and Guangdong Province
Hemoglobin, 10/23/09 Relevance Score: 89%

Iron chelation therapy in the management of thalassemia: the Asian perspectives
International Journal of Hematology, 11/04/09 Relevance Score: 88%